Professional Documents
Culture Documents
Werkcollege Farmaco-Epidemiology: Prof. Dr. Eelko Hak
Werkcollege Farmaco-Epidemiology: Prof. Dr. Eelko Hak
Werkcollege Farmaco-Epidemiology: Prof. Dr. Eelko Hak
Confounding triangle:
VACCINE DEATH
Table 1: Table 2:
association with CONFOUNDER association with
Vaccine Death
Age?
Gender?
N med?
Exercise 1. Examination vaccinated and non-vaccinated
1. To analyze data per subgroup, please use data -> data split file, compare
groups, click on variable domain and move to box “groups based on”, click
OK.
2. Examine each of the variables in the dataset (analyze -> descriptives). Use
frequencies for the categorical variables and descriptives or explore for the
continues variables.
Variable Categorical/continuous
Age
Gender
N_med
Vaccine
Death
3. Fill out table 1. This gives the association between vaccine (the determinant)
and the covariates that are potential confounders.
4. Use t-tests for continues variables to compare means (and SD) between
vaccinated and non-vaccinated. Go to analyse, compare means, independent
sample t-test. Define vaccine as grouping variable and define the levels (0, 1).
Put in all continuous variables in the test variable.
If Levene’s test > 0.05 first line; If Levene’s test =< 0.0.5 second line
2. Do you think there might be a potential for confounding bias? For which variables
and why? How is the mean risk of vaccinated as compare with non-vaccinated
groups?
3. Is the potential for confounding less likely or more likely among the 18-64 year
group as compared to the 65+ high-risk elderly?
Confounders are variables that are related to the exposure status and the outcome
(case status). Variables that are not associated with the exposure status will never be
a confounder and therefore do not need to be examined for an association with the
outcome.
Question 1. For each sub-cohort, please encircle the potential confounders in table 1.
Question 2. Present distribution of potential confounders (erase variables that are not
potential confounders) for those who died during the epidemic (case) and controls.
Table 2.
Question 3. For each sub-cohort, please encircle the confounders (both associated
with exposure and outcome status) in table 2.
Table 3.
High-risk 65+
DEATH 0.61 (0.43 – 0.88) 40% (12 – 57) 0.56 (0.38 – 0.82) 44% (18 – 62)
Question 3. Would you, based on the adjusted and unadjusted estimates, conclude
that there is confounding present in the data? How does confounding affect the
outcome in this dataset?